| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:2215.)
© 2003 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology and Clinical Research Institute, Seoul National University Hospital, Seoul (E-C.S., K.C., K-H.J., M.K., B-W.Y.); Neuroscience Research Institute of Seoul National University Medical Research Center, Seoul (E-C.S., K.C., K-H.J., M.K., B-W.Y.); Department of Neurology, Seoul National Hospital, Seoul (K.C.); Department of Neurology, Ilsan Paik Hospital, Inje University, Ilsan (S-W.J.); and Department of Neurology, Gangwon University, Chunchon (S-H.K.), South Korea. Dr Song and Dr Chu contributed equally to this work.
Reprint requests to Byung-Woo Yoon, MD, PhD, Department of Neurology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110-744, South Korea. E-mail bwyoon{at}snu.ac.kr
Background and Purpose Hyperglycemia has a deleterious effect on brain ischemia. However, the effect of hyperglycemia in intracerebral hemorrhage (ICH) is not well known. We investigated the effect of hyperglycemia on the development of brain edema and perihematomal cell death in ICH.
Methods Hyperglycemia was induced by intraperitoneal injection of streptozotocin (60 mg/kg) in adult Sprague-Dawley male rats. ICH was induced by stereotaxic infusion of 0.23 U of collagenase into the left striatum. Seventy-two hours after ICH, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) staining was performed for perihematomal cell death. We also measured brain water content to evaluate edema formation.
Results The serum glucose level of the hyperglycemic group was 394.0±180.3 mg/dL (n=31), and that of the normoglycemic group was 97.5±27.4 mg/dL (n=31). The size of hemorrhage was similar between groups, without any significant difference (n=8 in each group). The brain water content of hyperglycemic rats (n=17) increased in both lesioned (81.0±0.5%) and nonlesioned hemispheres (78.7±0.6%) compared with the normoglycemic group (n=17; lesioned: 78.9±0.8%; nonlesioned: 77.3±1.1%). In the hyperglycemic group, more TUNEL-positive cells were found in the perihematomal regions (n=6).
Conclusions Hyperglycemia caused more profound brain edema and perihematomal cell death in experimental ICH.
Key Words: brain edema hyperglycemia intracerebral hemorrhage neuronal death streptozotocin
This article has been cited by other articles:
![]() |
Y.-C. Chuang, Y.-M. Chen, S.-K. Peng, and S.-Y. Peng Risk stratification for predicting 30-day mortality of intracerebral hemorrhage Int. J. Qual. Health Care, December 1, 2009; 21(6): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. S. Latorre, S. H.-Y. Chou, R. G. Nogueira, A. B. Singhal, B. S. Carter, C. S. Ogilvy, and G. A. Rordorf Effective Glycemic Control With Aggressive Hyperglycemia Management Is Associated With Improved Outcome in Aneurysmal Subarachnoid Hemorrhage Stroke, May 1, 2009; 40(5): 1644 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. James, P. M. Sullivan, C. D. Lascola, M. P. Vitek, and D. T. Laskowitz Pharmacogenomic Effects of Apolipoprotein E on Intracerebral Hemorrhage Stroke, February 1, 2009; 40(2): 632 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Zubkov, J. N. Mandrekar, D. O. Claassen, E. M. Manno, E. F. M. Wijdicks, and A. A. Rabinstein Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage Arch Neurol, October 1, 2008; 65(10): 1320 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viswanathan, J.-P. Guichard, A. Gschwendtner, F. Buffon, R. Cumurcuic, C. Boutron, E. Vicaut, M. Holtmannspotter, C. Pachai, M.-G. Bousser, et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study Brain, September 1, 2006; 129(9): 2375 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Frontera, A. Fernandez, J. Claassen, M. Schmidt, H. C. Schumacher, K. Wartenberg, R. Temes, A. Parra, N. D. Ostapkovich, and S. A. Mayer Hyperglycemia After SAH: Predictors, Associated Complications, and Impact on Outcome Stroke, January 1, 2006; 37(1): 199 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M.S. Nys, M. J.E. van Zandvoort, P. L.M. de Kort, H. B. van der Worp, B. P.W. Jansen, A. Algra, E. H.F. de Haan, and L. J. Kappelle The prognostic value of domain-specific cognitive abilities in acute first-ever stroke Neurology, March 8, 2005; 64(5): 821 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Flibotte, N. Hagan, J. O'Donnell, S. M. Greenberg, and J. Rosand Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage Neurology, September 28, 2004; 63(6): 1059 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Jung, K. Chu, S.-W. Jeong, S.-Y. Han, S.-T. Lee, J.-Y. Kim, M. Kim, and J.-K. Roh HMG-CoA Reductase Inhibitor, Atorvastatin, Promotes Sensorimotor Recovery, Suppressing Acute Inflammatory Reaction After Experimental Intracerebral Hemorrhage Stroke, July 1, 2004; 35(7): 1744 - 1749. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lindsberg and R. O. Roine Hyperglycemia in Acute Stroke Stroke, February 1, 2004; 35(2): 363 - 364. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |